Table 1 Characteristics of analyzed individuals with laboratory-positive non-severe and severe COVID-19, Mexico 2020
Overall | Non-severe | Severe | p | |
|---|---|---|---|---|
n = 740 | n = 533 | n = 207 | ||
Sex | ||||
Female | 316 (42.7) | 257 (48.2) | 59 (28.5) | < 0.001 |
Male | 424 (57.3) | 276 (51.8) | 148 (71.5) | |
Age (years) a | 43.7 ± 14.9 | 40.0 ± 13.0 | 53.1 ± 15.4 | < 0.001 |
Age group (years) | ||||
15–29 | 141 (19.1) | 126 (23.6) | 15 (7.2) | < 0.001 |
30–44 | 281 (38.0) | 240 (45.1) | 41 (19.8) | |
45–59 | 210 (28.3) | 122 (22.9) | 88 (42.6) | |
≥ 60 | 108 (14.6) | 45 (8.4) | 63 (30.4) | |
Received NAIs (any) | ||||
No | 734 (99.2) | 529 (99.2) | 205 (99.0) | 0.769 |
Yes | 6 (0.8) | 4 (0.8) | 2 (1.0) | |
Received antyperitc drugs (any) | ||||
No | 326 (44.1) | 227 (42.6) | 99 (47.8) | 0.198 |
Yes | 414 (55.9) | 306 (57.4) | 108 (52.2) | |
Antipyretic drug received b | ||||
Acetaminophen | 372 (89.9) | 291 (95.1) | 81 (75.0) | < 0.001 |
Metamizole | 11 (2.7) | 5 (1.6) | 6 (5.6) | |
Ibuprofen | 10 (2.3) | 4 (1.3) | 6 (5.6) | |
Other | 21 (5.1) | 6 (2.0) | 15 (13.8) | |
Received influenza vaccine c | ||||
No | 622 (84.1) | 440 (82.6) | 182 (87.9) | 0.073 |
Yes | 118 (15.9) | 93 (17.4) | 25 (12.1) | |
Elapsed days from symptoms onset to health-care seeking | ||||
< 1 | 347 (46.9) | 253 (47.5) | 94 (45.4) | < 0.001 |
1–3 | 182 (24.6) | 148 (27.7) | 34 (16.4) | |
4 or above | 211 (28.5= | 132 (24.8) | 79 (38.2) | |
Hospital admission | ||||
No | 470 (63.5) | 470 (88.2) | 0 (0) | < 0.001 |
Yes | 270 (36.5) | 63 (11.8) | 207 (100) | |
Acute symptoms profile | ||||
Cough (yes) | 657 (88.8) | 466 (87.4) | 191 (92.3) | 0.061 |
Fever (yes) | 641 (86.6) | 451 (84.6) | 190 (91.8) | 0.010 |
Headache (yes) | 632 (85.4) | 464 (87.1) | 168 (81.2) | 0.041 |
Myalgia/Arthralgia (yes) | 572 (77.3) | 423 (79.4) | 149 (72.0) | 0.031 |
Odynophagia (yes) | 407 (55.0) | 310 (58.2) | 97 (46.9) | 0.006 |
Chills (yes) | 403 (54.5) | 287 (53.8) | 116 (56.0) | 0.591 |
Rhinorrhea (yes) | 353 (47.7) | 276 (51.8) | 77 (37.2) | < 0.001 |
Thoracic pain (yes) | 282 (38.1) | 171 (32.1) | 111 (53.6) | < 0.001 |
Diarrhea (yes) | 137 (18.5) | 104 (19.5) | 33 (15.9) | 0.262 |
Polypnea (yes) | 27 (3.6) | 5 (0.9) | 22 (10.6) | < 0.001 |
Personal history of | ||||
Tobacco use (current, yes) | 80 (10.8) | 47 (8.9) | 32 (15.6) | 0.009 |
Obesity (BMI 30 or higher) (yes) | 162 (21.9) | 100 (18.8) | 61 (29.7) | 0.001 |
Arterial hypertension (yes) | 148 (20.0) | 74 (13.9) | 74 (35.6) | < 0.001 |
Cardiovascular disease (yes) | 20 (2.7) | 8 (1.5) | 12 (5.9) | 0.001 |
Type 2 diabetes mellitus (yes) | 108 (14.6) | 51 (9.5) | 58 (27.8) | < 0.001 |
Asthma (yes) | 33 (4.4) | 22 (4.2) | 10 (4.9) | 0.676 |
COPD (yes) | 27 (3.7) | 9 (1.7) | 18 (8.8) | < 0.001 |
Chronic kidney disease (yes) | 13 (1.8) | 3 (0.6) | 10 (4.9) | < 0.001 |
Immunosuppression (yes) | 19 (2.5) | 8 (1.5) | 10 (4.9) | < 0.001 |
HIV infection (yes) | 5 (0.7) | 3 (0.6) | 2 (1.0) | 0.549 |